Market Overview

Global Blood Therapeutics (NASDAQ: GBT)

52.13 +1.59 (3.15%)

Analyst Ratings

DateResearch FirmActionCurrentPT
12/19/18Morgan StanleyMaintainsEqual-Weight55.0
8/06/18PiperJaffrayInitiates Coverage OnOverweight80.0
8/06/18WedbushMaintainsOutperform73.0
6/28/18Cantor FitzgeraldMaintainsOverweight96.0
6/28/18NomuraMaintainsBuy109.0
6/27/18H.C. WainwrightMaintainsBuy125.0
5/08/18OppenheimerMaintainsOutperform74.0
3/21/18Morgan StanleyDowngradesEqual-Weight
3/06/18Morgan StanleyMaintainsOverweight61.0
2/28/18Cantor FitzgeraldMaintainsOverweight72.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter